baber/WOPTO huggingface dataset:
Patent JP-2000507256-A (JP)
IPC: C07D401/04
Filed: 1997-03-24
Abstract: Compounds of formula (I) in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings given in the description, are novel effective bronchial therapeutic agents.
Patent JP-2000509315-A (JP)
Title: スタックからの改良されたつまみ上げ性、分配性、及び分離性を有するウェットワイプ
IPC: A47K10/42
Filed: 1998-02-05
Abstract: (57)【要約】
本発明は、ベビーワイプ、化粧の除去、及び他のスキンケアアプリケーションのような人体への使用に加え、家庭において及び工業において表面を拭くのに使用されるウェットワイプ（１）に関する。このウェットワイプは、顧客により、直ちに識別され、つかまれ、ウェットワイプ（１）のスタックから分離され得る改良されたリーディングエッジ（２）を提供される。これは、ワイプの隣接する表面間の接着力を減少させるように、ワイプ（１）の基体の少なくとも１つの表面の摩擦係数を減少させることにより達成される。
Patent JP-2000507876-A (JP)
Title: 空気から微粒子を除去する分離器
IPC: B01D50/00
Filed: 1997-04-08
Abstract: (57)【要約】
本発明は、空気流から微粒子を除去する分離器を提供する。分離器は、内部に比較的小さなフィルタを組み込んだ空気式の分離器であって、空気流から１ミクロンまでの微粒子を除去できる。ほとんどの微粒子を除去するために、空気式の分離器は、渦巻効果と空気流の急激な方向変化とを利用する。極微粒子は、上記方法で空気から除去するのに十分な質量を持たないので、これらの微粒子は、空気流内にとどまり、フィルタまで運ばれ、フィルタに堆積する。フィルタの周りに激しく流れる流入空気によって、堆積が妨害され、フィルタから堆積物の一部が取り除かれる。必要ならば、この不規則流れをバックフラッシングにより促進することができる。分離した微粒子とフィルタから除去した微粒子は、次の排出のために分離器内に蓄積する。
Patent JP-H11508830-A (JP)
IPC: B26F1/24
Filed: 1997-04-15
Abstract: A device for perforating webs of foil, in particular plastic foil, has at least one pair of rollers through which the foil is moved. The pair of rollers includes a spiked roller with spikes which extend radially from its outer surface, and a mating roller held against the spiked roller and whose outer surface has a lining which can be penetrated by the point of each spike, for example an elastic outer ply. The outer surface of the spiked roller has at least one recess in which a spike is arranged in such a way that only a section of its point protrudes by a predetermined extent beyond the outer surface.
Patent JP-2000510169-A (JP)
Title: 還元された二酸化チタンで被覆された二酸化ケイ素小板を基礎とする光輝顔料
IPC: C08K3/00
Filed: 1997-04-03
Abstract: (57)【要約】
本質的に二酸化チタンからなる被覆で二酸化ケイ素小板を被覆し、かつ引き続き、被覆された小板を還元雰囲気中で加熱することにより得られる、被覆された二酸化ケイ素小板を基礎とする光輝顔料ならびに該光輝顔料の製造及び、塗料、印刷インキ、インキ、プラスチック、ガラス、セラミック製品及び装飾的化粧品調製物の着色のための該光輝顔料の使用。
Patent JP-2001522419-A (JP)
Title: 移動するフィラメントのための連続均一染色プロセスおよびこのプロセスを実行するための設備
IPC: D06B21/00
Filed: 1998-02-20
Abstract: (57)【要約】
本発明は、巻き出された糸を連続的に無地染めする方法に関し、本質的に、１つまたは複数の支持体（１）から連続的に糸を巻き出す段階と、それに染料を含浸させる段階（２）と、それを固着させる（４）前に前記染料を前固着させる段階（３）と、任意での洗浄段階（１０）と、前記糸を乾燥させる段階（５）と、それを巻き戻す段階（６）とを含む。さらに、本発明は、この方法を実施するための設備に関する。この方法は、少なくとも１つの補足的な絞り操作（８）および／または含浸操作が、染料を固着させる（４）前に実行されることを特徴とする。本発明は、織機あるいはカーペットタフィング機によく使用される織編用糸を染めるのにとくに有効である。
Patent JP-2001524970-A (JP)
Title: ウイルス不活性化方法およびそれに用いるための組成物
IPC: A61K41/00
Filed: 1998-04-28
Abstract: (57)【要約】
本発明は、赤血球組成物中に含有された感染性ウイルスのレベルを低減するための方法を提供する。本方法は、該組成物をリポソーム担体中に処方された光増感剤と接触させ、そして該組成物中に含有された感染性ウイルスのレベルを低減するのに十分な波長、線量および持続時間で該組成物を光に曝露する工程を包含する。本発明の方法では、光の適用前に、単独でまたはリポソーム中に処方された消光剤も赤血球組成物に付加し得る。本発明は、本発明の方法に用いるための、特定のリポソーム担体中に処方された光増感剤ならびにリポソーム担体中に処方された消光剤を含有する組成物も提供する。
Patent JP-2000515026-A (JP)
Title: 低温濾過ビールの製造法
IPC: C02F1/44
Filed: 1998-05-13
Abstract: (57)【要約】
本発明は低温濾過されたビールの製造法に関する。前記の方法に従うと、ビールは、カルシウムイオンを吸収することができる膜フィルターを通して濾過される。濾過後、前記の膜フィルターは、水性物質により洗浄され、リンスされる。次に、洗浄され、リンスされた膜フィルターを再使用することができる。本発明は、５．０未満のｐＨをもつ酸性水性物質がリンスのために使用されること又は、リンスのために使用される物質が、それが含有するカルシウムの量を減少させるために処理されることを特徴としている。本発明の方法は、噴き出しの傾向の少ないビールを製造する手段を提供する。
Patent JP-2001524874-A (JP)
Title: 周期的プロフィール内注入を伴う単一カラム閉鎖ループリサイクリング
IPC: G01N30/44
Filed: 1998-05-05
Abstract: (57)【要約】
定常状態において、即ち（ａ）カラムおよび１つの溶媒ポンプを通す循環クロマトグラフィープロフィールを構築しそして維持すること；（ｂ）少なくとも２つの成分からなる試料を該維持循環プロフィールの中へ不連続的または周期的に注入すること；そして（ｃ）少なくとも２つの濃縮フラクションを該循環プロフィールから不連続的または周期的に捕集することを含む、単一カラムをを用いて循環的に分取クロマトグラフィーを行う方法。
Patent JP-2002500854-A (JP)
Title: セクタ準拠配信システムおよび方法
IPC: H04B7/185
Filed: 1999-03-22
Abstract: (57)【要約】
通信システム１０は地上局３０および基地局４０と通信する複数の衛星２０を有する。衛星２０は、地球５２を周回する非静止軌道内にある。第１地上局３０がデータ・パケットを衛星２０に送信する。このデータ・パケットは、目的の地上局３１が位置する地球５２上の地域を表すセクタ番号を含む。衛星２０がセクタ番号により識別される地域にサービスを提供していない場合は、衛星２０は、データ・パケットを別の衛星２０に送信する。この段階は、セクタ番号により識別される地域にサービスを提供している可能性が最も高い、最も可能性のある衛星２０にデータ・パケットが到達するまで繰り返される。最も可能性のある衛星２０がセクタ番号により識別される地域に依然としてサービスを提供している場合は、その衛星がデータ・パケットを目的地上局３１に送信する。
Patent JP-2002514305-A (JP)
IPC: B82B1/00
Filed: 1998-05-13
Abstract: Disclosed is a sensor for sensing the presence of an analyte component without relying on redox mediators. This sensor includes (a) a plurality of conductive polymer strands each having at least a first end and a second end and each aligned in a substantially common orientation; (b) a plurality of molecular recognition headgroups having an affinity for the analyte component and being attached to the first ends of the conductive polymer strands; and (c) an electrode substrate attached to the conductive polymer strands at the second ends. The electrode substrate is capable of reporting to an electronic circuit reception of mobile charge carriers (electrons or holes) from the conductive polymer strands. The electrode substrate may be a photovoltaic diode. Also disclosed is method of forming a sensor capable of sensing the presence of an analyte component. This method includes (a) contacting a sensor substrate (e.g., a device element of a device on semiconductor chip) with a first medium containing mobile conductive polymer strands or precursors of the conductive polymer strands; (b) applying a first potential to the substrate sufficient to form a first structure having the conductive polymer strands affixed into the substrate; (c) contacting the sensor substrate, with affixed conductive polymer strands, with a second medium containing mobile molecular recognition headgroups; and (d) applying a second potential to the substrate sufficient to affix the molecular recognition headgroups to the affixed conductive polymer strands.
Patent MD-20040154-A (MD)
Title: Plastic counter
Inventor: CUHARCIUC IGOR
IPC: A44C21/00
Filed: 2004-06-23
Abstract: The invention relates to a disk-shaped counter serving as payment means in those fields, permitting the automated payment, as game fish for casino, with high protection degree.The counter represents a plastic disk-shaped body (1), homogenous by its physical structure. The three coloured many-coloured zones (5, 6, 7) with clear borders between them, embrace the counter's sides (2) and (3) and contain bas-relief imprints (4) onto one or both sides.
Patent MX-154837-A (MX)
Inventor: USRY JOE DEAN
IPC: A61M16/20
Filed: 1984-06-19
Abstract: The system includes a manifold (4) for applying gas pulses to a person, a first conduit (44) for supplying gas from a gas source (68) to the manifold (4), and a first valve (72) disposed on the conduit (44) adjacent to the manifold (4) for interrupting the flow of gas through the conduit (44) to thereby produce gas pressure pulses which flow to the manifold (4). A second conduit (40) coupled between the gas source (68) and the manifold (4) is also provided. A second valve (80) is disposed in the second conduit (40) to normally block the flow of gas therethrough and for periodically opening to allow gas to flow to the manifold (4). A pressure transducer (84) is disposed between the second valve (80) and the manifold (4) for detecting the pressure in the manifold (4) and for supplying a signal to the gas source (68) indicating what the pressure in the manifold (4) is. The manifold (4) includes a first lumen (12) for carrying gas from the gas source (68) to the person, and a second lumen (8) coupled to the second conduit (40) through which the pressure in the manifold (4) is determined.
Patent NZ-197237-A (NZ)
Title: Hydrocarbyl omega-(4-(3-(isopropyl or t-butylamino)propoxy)phenyl)alkanoates
Inventor: CARLSSON E I
IPC: A61K31/22
Filed: 1981-05-29
Abstract: The present invention relates to new compounds of the formula I <CHEM> as well as their preparation, pharmaceutical preparations containing same, and method of treating acute myocardial infarction. The compounds which possess beta-adrenoceptor blocking activity are very shortacting and are intended for treatment of acute myocardial infarction by administration by means of injection.
Patent NZ-211525-A (NZ)
Title: Immunosuppressant factor from human glioblastoma cells
Inventor: FONTANA ADRIANO
IPC: C07K14/005
Filed: 1985-03-21
Abstract: An immunosuppressant factor and factor which exhibits interleukin-1-like activity, derived from human glioblastoma cells.
Patent NZ-213604-A (NZ)
Title: Use of 4-((alpha-methyl)-2,3-dimethylbenzyl)-imidazole as a veterinary sedative-analgesic agent
Inventor: VIRTANAN R E
IPC: A61K31/415
Filed: 1985-09-25
Abstract: 4-[(α-Methyl)-2,3-dimethyl-benzyl]imidazole is useful as a veterinary sedative-analgetic agent, especially in small mammals.
Patent NZ-219460-A (NZ)
Title: Coating compositions containing metal pigments
Inventor: VACHLAS Z
IPC: C09D5/38
Filed: 1987-03-02
Abstract: An aqueous coating composition comprising a film-forming material, a metallic pigment, phosphate inhibitor being either an orthophosphoric acid or an organic acid ester of phosphoric acid containing a group of formula (I):a cationic salt of one or more of the following metals: sodium, potassium, magnesium, calcium, strontium, barium, vanadium, cobalt, nickel, copper, zinc or silver; and a water containing diluent.
Patent NZ-223987-A (NZ)
Title: Carton with handle opening: opening closed by a biased flap
Inventor: SCHUSTER R L
IPC: B65D/
Filed: 1988-03-23
Abstract: A carton contains a flap on the outer top panel and a flap on the inner top panel, the free edge of the outer top panel flap overlying the inner top panel flap. When a user presses down on the outer top panel flap, it pivots out of the way to allow the user's fingers to fold the inner top panel flap under the top panel structure to provide a handle for lifting the carton. When the fingers are withdrawn, the outer top panel flap is biased upwardly by its arcuate foldable connection to close the handle opening. If the inner top panel flap is contacted by the outer top panel flap as it pivots upwardly, the outer top panel flap pushes the inner top panel flap up to a substantially closed position. Score lines extending from the ends of the foldable connections of the inner and outer top panel flaps to the corners of the carton distribute the lifting stresses to the side panels of the carton.
Patent NZ-227157-A (NZ)
Title: Food products with fat or cream replaced by macrocolloid
Inventor: SINGER NORMAN S
IPC: A23L33/00
Filed: 1988-12-01
Abstract: New frozen whipped dessert foodstuffs have fat and/or oil partially or totally replaced by a macrocolliod. The macrocolloid comprises non-aggregated particles of denatured protein of mean dia. in the dry state of 0.1-2.0 microns. Less than 2% of the particles exceed 3.0 microns dia. and the particles are mainly spheroidal (800x optical microscopy). - Pref. the macrocolloid replaces dairy fat. It replaces over 50% (100% of the fat and/or oil). The foodstuff is an analog of ice cream contg. under 1% fat. The protein is denatured dairy whey protein, egg albumen, soy or bovine serum albumin. The foodstuff has at least 1x10 power 8 (9-12) particles per cc having dia. 0.5-2.5 microns. It contains less than 1% fat. The desserts are pred. from a premix of 5-20% protein, (25-100% of which is heat coagulable), by heat pasteurisation and high shear conditions. Cream substitute, sauces icing, cream pie fillings, spread and dips are new.
Patent NZ-236549-A (NZ)
Title: Platelet-derived growth factor b chain analogues
Inventor: THOMASON ARLEN READ
IPC: C12R1/19
Filed: 1990-12-19
Abstract: Novel platelet-derived growth factor (PDGF) analogs are provided in accordance with the present invention. Also provided is a method for the production of homogeneous quantities of these novel analogs. The novel analogs of the present invention, when refolded, have substantially the same biological activity as naturally occurring PDGF B109. The method of the present invention employs the use of a stop codon on the c-sis gene, or other coding sequence for a precursor protein of PDGF B109, or analogs thereof, at a position corresponding to a location from about amino acid 111 to about amino acid 160. The method of the present invention results in the production of relatively large homogeneous quantities of recombinant PDGF B analogs from high expression host cells, such as E. coli.
Patent NZ-241293-A (NZ)
Title: Substituted ((1,2,4-oxadiazol-5-yl)-1-imidazolylmethyl) biphenyl-2-yl-1h-tetrazole derivatives and medicaments
Inventor: BINDER DIETER
IPC: A61K31/415
Filed: 1992-01-14
Abstract: Tetrazole derivatives of the formula   <IMAGE> (I)  in which R1 denotes a saturated or unsaturated, straight-chain or branched (C1-C6) alkyl radical and R2 denotes methyl or ethyl, and their pharmaceutically usable salts.
Patent NZ-266074-A (NZ)
Title: Preparatory process of chiral intermediate furon derivatives and intermediate compounds therefor
Inventor: SAKSENA ANIL K
IPC: C07C69/63
Filed: 1994-04-28
Abstract: Disclosed is a process for preparing chiral compounds of the formula (I)    <IMAGE>  (I)  wherein: X1 and X2 are independently F or Cl; and E is -SO2R2, wherein R2 is C1-C6 alkyl, -C6H4CH3 or -CF3; its enantiomer and racemates thereof, useful in the synthesis of tetrahydrofuran azole antifungals. Novel compounds of the formula   <IMAGE>   or   <IMAGE>   wherein: X1 and X2 are independently F or Cl; B represents -C(O)Q* or -CH2OR''; Q* represents a chiral auxiliary group; R'' represents a hydroxy protecting group selected from -CH2C6H5, or -C(O)R1, wherein R1 is C1-C6 alkyl; and A represents Cl, Br, I or triazolyl; are also disclosed.
Patent NZ-268629-A (NZ)
Title: Prodrugs of protein tyrosine kinase inhibitors; such compounds linked to a protecting group capable of being cleaved to release the inhibitor
Inventor: SPRINGER CAROLINE JOY
IPC: A61K47/48
Filed: 1994-07-15
Abstract: PCT No. PCT/GB94/01532 Sec. 371 Date Jul. 1, 1996 Sec. 102(e) Date Jul. 1, 1996 PCT Filed Jul. 15, 1994 PCT Pub. No. WO95/02420 PCT Pub. Date Jan. 26, 1995A compound which comprises a prodrug of a protein tyrosine kinase inhibitor (PTKi) linked to a protecting group which is capable of being cleaved from the compound to release the PTKi, said PTKi prodrugs including tyrphostins, of formula (I),   N->O, n is 1 to 3; each group R1, which may be the same or different is H, OH, mercapto, carboxy, formyl, C1-4 alkyl, C2-4 alkenyl, C1-4 alkoxy, C1-4 alkylthio, carboxyC1-4 alkyl, carboxyC2-4 alkenyl, C1-4 alkylsulphoxy, halo, nitro, amino, C1-4 alkylamino, or C1-4 dialkylamino, or when n is 2 or 3 two R1 groups may together form a methylenedioxy or ethylenedioxy group; R2 is H, OH, C1-4 alkyl or together with position 2 of the ring to which the group(s) R1 is (are) attached forms a 5 or 6 membered aliphatic or heterocyclic ring, optionally containing a ketone group; and R3 is cyano, carboxy, carbamoyl, thiocarbamoyl, C(O)HNCH2CN, C(NH2)=C(CN2), an alpha keto C(O)R4 where R4 is 3,4-dihydroxyphenyl or 2-thiophene or an alpha amido C(O)NHR5 where R5 is benzyl, phenyl, or 2,4-dimethoxyphenyl; provided that at least one of R1 and R2 is mercapto, hydroxy or amino.
Patent NZ-285092-A (NZ)
Title: The hydrochloride salt of a pentapeptide, preparation and precursor
Inventor: AMBERG WILHELM
IPC: C07K7/06
Filed: 1995-04-26
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
Patent NZ-315357-A (NZ)
Title: Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine
Inventor: FANGET BERNARD
IPC: A61K39/00
Filed: 1996-07-29
Abstract: PCT No. PCT/FR96/01195 Sec. 371 Date Aug. 13, 1998 Sec. 102(e) Date Aug. 13, 1998 PCT Filed Jul. 29, 1996 PCT Pub. No. WO97/04803 PCT Pub. Date Feb. 13, 1997A method is disclosed for industrially producing a Japanese encephalitis vaccine, wherein (a) cells from a cell line are cultured, (b) the resulting cell culture is inoculated with a Japanese encephalitis virus in the presence of a viral growth medium, (c) the virus is propagated and multiplied on the cells, (d) the viral growth medium is recovered in the form of a suspension of viruses produced by the cells, (e) the virus suspension is purified in at least one ion exchange chromatography step and a gel permeation step, and (f) the virus suspension is formulated and converted into a pharmaceutical form to preserve it until the moment of use. A Japanese encephalitis vaccine characterised in that it comprises a Japanese encephalitis virus produced by culturing cells from a cell line, and in that the cellular DNA content is less than 100 pg/dose, is also disclosed.
Patent NZ-319819-A (NZ)
Title: Calcitriol derivatives and their uses
Inventor: DELUCA HECTOR F
IPC: A61P19/08
Filed: 1996-09-20
Abstract: A vitamin D derivative providing for the gradual in vivo release of a biologically active vitamin D compound and thereby regulating the in vivo availability and activity profile of the biologically active vitamin D compound, having the structure 1 Where R5 and R6 represent hydrogen, or taken together R5 and R6 are methylene R is represented by the structure 2 where Z is selected from various hydrocarbon groups with provisos to exclude prior art. Also claimed is a method of regulating the activity profile of a vitamin D compound where the hydroxy group at carbon 25, and a selected acyl group or a hydrocarbyloxycarbonyl group attached to the oxygen of the hydroxy group at carbon 25 will provide a modified vitamin D derivative that will prolong the in vivo activity profile of the vitamin D compound.
Patent NZ-322355-A (NZ)
Title: Package closing label comprises a first permanent portion and second temporary portion
Inventor: SMALL TOBBY LYNN
IPC: G09F3/10
Filed: 1996-11-08
Abstract: A packaging label 10 includes a first portion 11 with permanent pressure sensitive adhesive 17 on its bottom face and a second portion 21 substantially perpendicular to first portion 11 and having permanent pressure sensitive adhesive 35 on the bottom face remote from first portion 11.  Second portion 21 includes nutritional information and bar coding since the label is typically used with clam shell plastic packages for fruits or other food items.  First portion 11 of the label is adhesively secured to the lid of a clam shell container and after the container is filled with food items, the lid is closed, second portion 21 of the label is unfolded from a compact position which facilitates stacking and transportation, and the adhesive on second portion 21 is secured to the bottom of the container, holding the lid closed.  The bar coding is preferably on the top face of second portion 21 opposite the adhesive so that it can be scanned merely by dragging the bottom of the container over a scanner (e.g., in a grocery store).
Patent NZ-332194-A (NZ)
Title: Inductively powered battery charger
Inventor: BOYS JOHN TALBOT
IPC: H02J7/00
Filed: 1997-05-02
Abstract: Loosely coupled inductive power for charging batteries is rectified from a first power pickup winding and the resulting current source is connected to a battery unit (309). Each current source is controlled by shorting a second resonant winding (304). Battery banks may be charged using multiple isolated position-tolerant pickups independently controlled according to the condition of the connected battery unit and by overall commands communicated over an isolated link. The battery unit may be a single cell. In a self-stabilising bank or monoblock a primary inductive conductor is energised using all the cells, individual cells are separately monitored by control means and any below-average cell can be individually charged from the inductive conductor, thus correcting between-cell variations. The charge in all cells within a bank can be held within (for example) 30 % to 70 % of full charge and prevented from drifting towards full or empty during repetitive charge and discharge times.
Patent NZ-334788-A (NZ)
Title: Self-verifying security documents
Inventor: TAYLOR JOHN CHARLES
IPC: B44F1/12
Filed: 1997-10-08
Abstract: A security document such as a banknote 1 comprises a sheet 2 formed from a substrate bearing indicia 3 having self-verifying means.  Sheet 2 has an indicia-free portion 5 of transparent plastics material.  Transparent indicia-free portion 5 includes a self-verifying means including a colour tinted optical filter for viewing an area printed with metameric inks on the same or another similar security document.
Patent NZ-500441-A (NZ)
Title: Preparation of benzo-2-triazole substituted compounds for use in treating chemokine mediated diseases
Inventor: WIDDOWSON KATHERINE L
IPC: C07C255/50
Filed: 1998-01-23
Abstract: Processes are described for the preparation of a diamine (3-scheme 8) and a benzotriazole (4-scheme 8) as pharmaceutical compositions, and the use thereof in treating a chemokine mediated disease.  Members of a chemokine family include IL-8, GRO-alpha, GRO-beta, GRO-gamma and NAP-2. Commercially available 2-bromo-5-nitroaniline (1-scheme 8) can be reacted with copper (I) cyanide and pyridine in an aprotic solvent such as DMF to form the 2-cyano-5-nitroaniline (2-scheme 8). The diamine (3-scheme 8) can be formed by reacting 2-cyano-5-nitroaniline (2-scheme 8) with tetramethyl hydrazine iodide and a strong hindered base such as sodium t-pentoxide, in an aprotic solvent such as DMSO. The 7-amino-4-cyanobenzotriazole (4-scheme 8) is made by reacting the diamine (3-scheme 8) with sodium nitrite, in a protic solvent such as HOAc, followed by reduction of the nitro group with a suitably reducing agent, such as Pd/C in MeOH.  It can then be converted to the corresponding urea by condensation with a commercially available isocyanate.
Patent NZ-506111-A (NZ)
Title: Line bridging pots/dsl filter splitter
Inventor: ZOISS EDWARD J
IPC: H01R13/719
Filed: 2000-08-03
Abstract: A portable POTS/data filter/splitter device provides line-bridging connectivity between a craftsperson's test set and a metallic tip and ring pair.  A data/audio filter prevents corruption of data signals to provide the craftsperson with POTS access to the line.  The device includes a Y shaped housing 20, 30 containing respective port sections 12, 13, 14, terminal ends of which contain a line jack 32, and audio/voice jack 33 and a data jack 34.  A printed circuit board including a voice/data isolation filter 60 is installed in the housing and interfaced to the line, voice, and data jacks and to a set of line attachment leads 42, 52 at the line jack.  The device allows placement of a POTS call from the test set connected to the voice jack during the transport of data signals on the line, without interfering with the data signals.
Patent NZ-507890-A (NZ)
Title: An extruded retainer member for retaining a glass pane or panel within a frame
Inventor: CRICHTON DAVID
IPC: E06B3/62
Filed: 2000-10-31
Abstract: A retainer member (3) adapted to retain a pane or panel edge (2) within a longitudinally extending frame member (1) along the pane or panel edge (2), comprises a base portion (4) of the retainer member and two side portions (5, 6) one of which is longer than the other.  The position of the panel (2) relative to the frame member (1) may be adjusted until the longer side portion (6) of the retainer member (3) is also pushed in and sealed fully home between the frame member (1) and the pane or panel edge (2) along the length of the retainer member (3) to fix the position of the panel (2).
Patent NZ-508292-A (NZ)
Title: Treatment of migraine symptoms with ibuprofen and salts thereof
Inventor: CODISPOTI JOSEPH R
IPC: A61P25/06
Filed: 2000-11-20
Abstract: Use of ibuprofen as the sole pharmaceutically effective ingredient in the treatment of photophobia and phonophobia associated with migraine.